Aspirin Market Share, Trends, Future Outlook, Analysis and Forecast 2023-2030

The global aspirin market is anticipated to grow at a considerable CAGR of 3.6 % during the forecast period (2023-2030). Aspirin can be used to treat a wide range of diseases, including cancer, diabetes, cryptococcal infection, and abnormalities of the nervous system, owing to it has an impact on both Cyclooxygenase (COX)-dependent and Cyclooxygenase COX-independent pathways. Aspirin as one of the ingredients for creating specialized healthcare products such as hydrogels. The growing active pharmaceutical ingredient (API) industry would further stimulate the market growth of acetylsalicylic acid (commonly known as Aspirin) as an ingredient in therapeutic formulations. It is an analgesic and is used to get relief from acute pain. It is highly effective against muscle pain, bloating, skin irritation, gastric distension. It is also used for the treatment of migraine. It is effective against cluster headaches.

To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/aspirin-market

Owing to such benefits, there is spike in various drug
approvals activities across the globe, which is the primary factor supporting the market growth. For Instance, in March 2023, Vazalore, PLx Pharma's liquid-filled aspirin capsule, received FDA approval. In several ways, the formulation surpassed enteric-coated and immediate-release aspirin in clinical testing. According to FDA, in individuals with cardiovascular disease or who have already experienced a heart attack or stroke, aspirin has been demonstrated to be beneficial when administered daily to reduce the risk of heart attack, clot-related strokes, and other blood flow issues.

In March 2023, Janssen Pharmaceutical Companies of Johnson & Johnson announced for patients with peripheral arterial disease (PAD), XARELTO® is the first and only anticoagulant that has been licensed for use in conjunction with aspirin to lower the risk of significant thrombotic vascular events. Further, in February 2023, Bayer launched a new aspirin advertising campaign that links heart health and the stress of sports fanaticism. Additionally, Bayer is working with NBC Sports and Bally Sports to develop multimedia content and regional media partnerships with TV personalities and sports figures.

Market Coverage

• The market number available for - 2022-2030
• Base year- 2022
• Forecast period- 2023-2030
• Segment Covered-
o By Route of Administration
o By Dosage Form
o By Treatment
o By Product Type
o By Distribution Channel
• Regions Covered-
o North America
o Europe
o Asia-Pacific
o Rest of the World
• Competitive Landscape- includes Bayer AG, Cardinal Health, LNK International, Inc., Mayne Pharma Group Ltd., and others.

Key questions addressed by the report

• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• Who is the leader in the market?
• How are players addressing challenges to sustain growth?
• Where is the investment opportunity?

Global Aspirin Market Report Segment

By Route of Administration

• Oral
• Rectal
• Parenteral

By Dosage Form

• Tablets
• Intravenous Injections
• Capsules
• Syrups
• Others (Extended Release, Delayed Release, Chewable)

By Applications

• Pain
• Deep vein Thrombosis
• Fever and Inflammation
• Others

By Product Type

• Alone
• Combination Products

By Distribution Channel

• Hospitals Pharmacies
• Retail Pharmacies
• Online pharmacies

A full report of Aspirin Market available @ https://www.omrglobal.com/industry-reports/aspirin-market

Global Aspirin Market Report Segment by Region

North America

• United States
• Canada

Europe

• Germany
• United Kingdom
• France
• Spain
• Italy
• Rest of Europe

Asia-Pacific

• China
• Japan
• India
• Rest of Asia-Pacific

Rest of the World

• Middle East & Africa
• Latin America

Company Profiles

• Advance Pharmaceutical Inc.
• Alta laboratories Ltd.
• Endo International plc
• Globalimpoter Inc.
• Globela Pharma Pvt Ltd.
• J.M Loveridge Ltd.
• JQC (Huayin) Pharmaceutical co., Ltd.
• Nanjing Pharmatechs Co., Ltd.
• Perrigo Company plc
• Seqens
• St. Joseph Aspirin

Reasons to Buying From us -

1. We cover more than 15 major industries, further segmented into more than 90 sectors.
2. More than 120 countries are for analysis.
3. Over 100+ paid data sources mined for investigation.
4. Our expert research analysts answer all your questions before and after purchasing your report.

Media Contact:

Contact Person: Mr. Anurag Tiwari
Email: anurag@omrglobal.com
Contact no: +91 780-304-0404
Company Name: Orion Market Research

About Orion Market Research

Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services. The company also offers Digital Marketing services through its subsidiary OMR Digital and Software development and Consulting Services through another subsidiary Encanto Technologies.

This release was published on openPR.